Logo

Purely Proteins Raises First-Round Venture Financing

Nov 26, 2003

NEW YORK, Nov. 26 (GenomeWeb News) - Purely Proteins of Cambridge, UK said late yesterday it had raised an initial round of venture financing, but did not disclose the amount of the financing.

 

The company's business involves purification of suites of human proteins, as well as drug discovery services for therapeutic targets of these proteins that brings together in silico and biochemical approaches, according to David Parry-Smith, COO.

 

The funding round was led by Avlar BioVentrues and Yorkshire Fund Managers.

Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.